The novel therapy of the medication represents a significant breakthrough in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide505834.blogofchange.com/42687121/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment